From Dr. Bredesen
Chief Science Officer
June 7, 2021•From Dr. Bredesen, News
Finally — Clinical Trial Demonstrates Reversal of Cognitive Decline
Dr. Bredesen writes about his successful clinical trial using precision medicine that addresses the multiple causes of Alzheimer's. Read More »
April 16, 2021•From Dr. Bredesen, News
Twists & Turns in a March for the Cure
The key to sustainable cognitive improvement is a multifactorial approach for the treatment of Alzheimer’s, identifying and addressing the root cause contributors to the decline. Read More »
March 17, 2021•From Dr. Bredesen
Spring Ahead for Better Health
Dr. Bredesen explains that living counter to our internal clocks (circadian rhythms) increases the risk for obesity, diabetes, hypertension, and heart disease, which are known risk factors for cognitive decline. Read More »
February 18, 2021•From Dr. Bredesen
New Clues for Optimized Treatment
Dr. Bredesen discusses the new clues that are leading to the enhanced precision medicine approach to treat neurodegenerative diseases such as Parkinson's, Alzheimer's and Lewy body dementia. Read More »
January 18, 2021•From Dr. Bredesen, News
Dr. Bredesen remains hopeful for the New Year with the COVID vaccines, the published clinical trial leading to precision protocols for preventing and reversing cognitive decline, just on the horizon. Read More »
December 25, 2020•From Dr. Bredesen
The New Year promises hope with personalized, precision medicine protocols for the prevention and reversal of cognitive decline that should serve as the "vaccine" for Alzheimer's disease. Read More »
December 8, 2020•From Dr. Bredesen
Flat-Earth Criticism of Alzheimer’s Success
Dr. Bredesen directly addresses his critics in a recent blog post Read More »
November 26, 2020•From Dr. Bredesen
Progress Despite 2020 Challenges
Some say this is a year to skip Thanksgiving — with COVID restrictions, deaths, and a rocky presidential transition, but there has been progress made with effective vaccines and our first clinical trial concluding at the end of this year. Read More »